Concepedia
Publication | Open Access
The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin’s lymphoma tumor growth by promoting apoptosis and autophagy
17
Citations
49
References
2023
Year
Page 1